Scholars Central

CommentaryPublished 31 May 2021

Esophageal Cancer Radiochemotherapy

Authors: Chandrakanth Batra

Journal of Cancer Clinical Trials

Volume 6 · Issue 4 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Esophageal malignancy is one of the ten most incessant tumors around the world. There are two significant histologies: squamous cell carcinomas, which show up more regularly in the upper piece of the throat, and adenocarcinomas, which are prevalently found in the distal part and at the gastroesophageal intersection. Most patients experience the ill effects of privately progressed tumors, for which the anticipation is as yet poor with a 5-year endurance pace of 15–25%. Treatment depends on histology, tumor stage, area of the tumor, execution status, age, and comorbidities and it comprises of a medical procedure, chemotherapy, or radiotherapy or a mix of these.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cancer Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Clinical Trials
  • SubjectOncology & Cancer
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Chandrakanth Batra”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels